Skip to main content
LIGAND PHARMACEUTICALS INC logo

LIGAND PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · LGND ISIN · US53220K5048 LEI · 5493008K7TB0IKP37H79 US Financial and insurance activities
Open in API
Filings indexed 1,392 across all filing types
Latest filing 2010-05-05 Regulatory Filings
Country US United States of America
Listing US LGND

About LIGAND PHARMACEUTICALS INC

https://www.ligand.com/

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that functions as a capital and technology partner to the life sciences industry. The company's business model focuses on acquiring and developing royalty-generating assets by investing in the clinical development and commercialization of medicines. It manages a large, diverse portfolio of economic rights to partnered programs across therapeutic areas such as oncology, kidney disease, diabetes, and rare conditions. In addition to its royalty business, Ligand develops and licenses its proprietary technology platforms to a global network of biopharmaceutical partners. Its key technologies include Captisol®, a chemically modified cyclodextrin used to improve the solubility and stability of active pharmaceutical ingredients, and the NITRICIL™ platform.

Recent filings

Filing Released Lang Actions
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions that the company issued a press release announcing its financial results for the quarter ended March 31, 2010, and that the press release is furnished as an exhibit. The document itself does not contain detailed financial statements or substantive financial data but rather references the press release. The length is 2907 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, such a document is best classified as a Regulatory Filing (RNS) because it is a current report announcing the earnings release but does not contain the earnings release itself or detailed financial data. Therefore, the classification is RNS with high confidence.
2010-05-05 English
10-Q Filing
Interim / Quarterly Report Q1 2010
2010-05-05 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes an amendment to a Research and License Agreement between Ligand Pharmaceuticals and Trevena, Inc. It does not contain financial statements or detailed financial analysis but rather a material definitive agreement update. The document length is 3599 characters, which is relatively short and focused on a specific event. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement of a material contract amendment and does not fit into more specific categories like Annual Report, Earnings Release, or M&A filings. Therefore, the appropriate classification is Regulatory Filings (RNS).
2010-05-03 English
DEF 14A Filing
Proxy Solicitation & Information Statement
2010-04-23 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content describes a merger completion, details about contingent value rights (CVRs), milestone payments, and related agreements. It does not contain comprehensive financial statements or detailed financial performance data typical of Annual Reports (10-K) or Interim Reports (IR). It is not a transcript, proxy, or governance document. The document is a regulatory announcement of a significant corporate event and related financial arrangements, fitting the category of a Regulatory Filing (RNS). The length (5721 characters) and detailed event description support this classification rather than a simple announcement (RPA).
2010-04-20 English
4 Filing
Director's Dealing
2010-04-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.